JP2024502479A5 - - Google Patents
Info
- Publication number
- JP2024502479A5 JP2024502479A5 JP2023541867A JP2023541867A JP2024502479A5 JP 2024502479 A5 JP2024502479 A5 JP 2024502479A5 JP 2023541867 A JP2023541867 A JP 2023541867A JP 2023541867 A JP2023541867 A JP 2023541867A JP 2024502479 A5 JP2024502479 A5 JP 2024502479A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide according
- variant
- functional fragment
- polynucleotide
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163136074P | 2021-01-11 | 2021-01-11 | |
| US63/136,074 | 2021-01-11 | ||
| US202163136611P | 2021-01-12 | 2021-01-12 | |
| US63/136,611 | 2021-01-12 | ||
| US202163263001P | 2021-10-25 | 2021-10-25 | |
| US63/263,001 | 2021-10-25 | ||
| US202163263508P | 2021-11-03 | 2021-11-03 | |
| US63/263,508 | 2021-11-03 | ||
| PCT/US2022/011878 WO2022150732A2 (en) | 2021-01-11 | 2022-01-10 | Chimeric receptor therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502479A JP2024502479A (ja) | 2024-01-19 |
| JP2024502479A5 true JP2024502479A5 (enExample) | 2025-01-20 |
Family
ID=82322745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541867A Pending JP2024502479A (ja) | 2021-01-11 | 2022-01-10 | キメラ受容体療法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220220187A1 (enExample) |
| EP (1) | EP4274898A4 (enExample) |
| JP (1) | JP2024502479A (enExample) |
| KR (1) | KR20230143140A (enExample) |
| AU (1) | AU2022205683A1 (enExample) |
| CA (1) | CA3204211A1 (enExample) |
| IL (1) | IL304292A (enExample) |
| MX (1) | MX2023008115A (enExample) |
| WO (1) | WO2022150732A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11771718B2 (en) * | 2017-10-18 | 2023-10-03 | Precigen, Inc. | Polypeptide compositions comprising spacers |
| GB202201927D0 (en) * | 2022-02-14 | 2022-03-30 | Kings College | Artificial microrna construct |
| CA3261027A1 (en) * | 2022-07-10 | 2024-01-18 | Precigen, Inc. | POLYCISTRONIC miRNA CONSTRUCTS FOR IMMUNE CHECKPOINT INHIBITION |
| CN121909290A (zh) * | 2023-07-10 | 2026-04-21 | 普瑞赛格恩公司 | α-1抗胰蛋白酶缺乏症的治疗 |
| WO2025029865A1 (en) * | 2023-07-31 | 2025-02-06 | Precigen, Inc. | Cd19-targeted car t cell therapy |
| WO2025101959A1 (en) * | 2023-11-08 | 2025-05-15 | Renbio, Inc. | Plasmid dna constructs for peptide hormone expression |
| US12435338B2 (en) | 2023-11-22 | 2025-10-07 | Wyvern Pharmaceuticals Inc. | Composition for regulating production of interfering ribonucleic acid |
| WO2025137580A1 (en) * | 2023-12-22 | 2025-06-26 | Antiger Therapeutics, Inc. | Class ii hla with inter-chain disulfide bond |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3783098A1 (en) * | 2013-05-14 | 2021-02-24 | Board Of Regents, The University Of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| CN106061488B (zh) * | 2013-12-02 | 2021-04-09 | 菲奥医药公司 | 癌症的免疫治疗 |
| CA3012344A1 (en) * | 2016-02-12 | 2017-08-17 | University Of Massachusetts | Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization |
| CA3065930A1 (en) * | 2017-06-07 | 2018-12-13 | Intrexon Corporation | Expression of novel cell tags |
| US11771718B2 (en) * | 2017-10-18 | 2023-10-03 | Precigen, Inc. | Polypeptide compositions comprising spacers |
| US11649455B2 (en) * | 2018-03-30 | 2023-05-16 | University Of Geneva | Micro RNA expression constructs and uses thereof |
| CA3105816A1 (en) * | 2018-07-10 | 2020-01-16 | Precigen, Inc. | Ror-1 specific chimeric antigen receptors and uses thereof |
| EP3963076A1 (en) * | 2019-05-02 | 2022-03-09 | Celyad | Cells with multiplexed inhibitory rna |
-
2022
- 2022-01-10 AU AU2022205683A patent/AU2022205683A1/en active Pending
- 2022-01-10 MX MX2023008115A patent/MX2023008115A/es unknown
- 2022-01-10 WO PCT/US2022/011878 patent/WO2022150732A2/en not_active Ceased
- 2022-01-10 JP JP2023541867A patent/JP2024502479A/ja active Pending
- 2022-01-10 EP EP22737272.9A patent/EP4274898A4/en active Pending
- 2022-01-10 CA CA3204211A patent/CA3204211A1/en active Pending
- 2022-01-10 US US17/572,618 patent/US20220220187A1/en active Pending
- 2022-01-10 KR KR1020237026326A patent/KR20230143140A/ko active Pending
-
2023
- 2023-07-06 IL IL304292A patent/IL304292A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024502479A5 (enExample) | ||
| JP7735373B2 (ja) | 多鎖キメラポリペプチドおよびその使用 | |
| CN112300269B (zh) | Kras突变特异性t细胞受体筛选及抗肿瘤用途 | |
| JP2019525914A5 (enExample) | ||
| JP2021177771A5 (enExample) | ||
| JP2023505492A5 (enExample) | ||
| JP2016514457A5 (enExample) | ||
| JP2019527055A5 (enExample) | ||
| JP2014221758A5 (enExample) | ||
| JP2020500510A5 (enExample) | ||
| JP2015212284A5 (enExample) | ||
| JP2021531265A5 (enExample) | ||
| JP2019530441A5 (enExample) | ||
| IL292650B2 (en) | COSTIMULATORY CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING IL13Ra2 | |
| JPH08510756A (ja) | ストレス蛋白質とその使用 | |
| JP2018524987A5 (enExample) | ||
| JP2014508748A5 (enExample) | ||
| JP2008525033A5 (enExample) | ||
| JP2021524275A5 (enExample) | ||
| JP2015524413A5 (enExample) | ||
| Guo et al. | γδ T cell antigen receptor polyspecificity enables T cell responses to a broad range of immune challenges | |
| JP2020532285A5 (enExample) | ||
| CN114736291B (zh) | 特异性结合发热伴血小板减少综合征病毒的囊膜蛋白Gn的人源单克隆抗体及其用途 | |
| CN111542546A (zh) | 抗lag-3 抗体及其用途 | |
| JP2020512284A5 (enExample) |